MedAdvisor signs Zest

AUSTRALIAN LISTED companies MedAdvisor and EBOS have inked a three year agreement linking EBOS subsidiary Zest with the medical management specialist.

The ultimate aim was stated as “further extending Zest services to pharmaceutical manufacturers and other program funders” an ASX announcement said.

The EBOS Group had invested significantly in MedAdvisor in Oct 2017 (PD 25 Oct 2017) and now, under the new agreement, MedAdvisor would provide a digital communication channel for Zest’s healthcare programs, supporting better connections with manufacturers and the community.

Zest is a provider of educational materials, web sites and awareness development programs, at both the health professional and consumer levels, as well as working to align public policy with patient needs.

The company can claim a successful track record in implementing programs for leading healthcare and pharmaceutical companies and says it will continue to provide high quality solutions together with MedAdvisor, which will take fees for delivery of programs.

MedAdvisor currently provides Patient Engagement Programs (PEPs) through its existing digital communications offering for around 14 of Australia’s leading pharmaceutical and healthcare companies.

MedAdvisor and Zest are already offering a program via PlusOne to an existing client.

MedAdvisor said it saw the partnership as potentially extending further as its hospital market expansion strategy rolls out through collaboration on tailored and customised hospital discharge programs.